| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 29, 2007
Accepted on May 24, 2007
Department of Endocrinology and Metabolism, Shanghai Jiaotong University Affiliated Sixth People's Hospital; Shanghai Diabetes Institute; Shanghai Clinical Center of Diabetes, Shanghai, China
* To whom correspondence should be addressed. E-mail: wpjia{at}sjtu.edu.cn.
Objective Previous studies have shown that adipose-derived serum retinol binding protein 4 (RBP4) levels are increased in insulin-resistant mouse models and in subjects with insulin resistance or type 2 diabetes. However, the association of visceral fat and serum RBP4 has not been studied. The purpose of this study was to investigate the relationship between serum RBP4 and regional fat distribution in Chinese subjects with and without type 2 diabetes.
Design We measured serum RBP4 concentrations from 1033 Chinese subjects with various degree of obesity and tested the association between visceral adposity and serum RBP4. In a subgroup of this study, euglycemic hyperinsulinemic clamp was performed to measure insulin sensitivity. The association between visceral adiposity and serum RBP4 was also determined in response to rosiglitazone treatment in a subgroup of patients with diabetes.
Results Serum RBP4 level was positively correlated with visceral adipose area in male (r=0.171, p<0.001) and female (r=0.215, p<0.001) subjects. However, there was no correlation between serum RBP4 and body-mass-index. Subjects with visceral obesity had higher serum RBP4 concentrations than those without visceral obesity in both men and women. Rosiglitazone treatment in patients with diabetes resulted in a lower serum RBP4 level (35.2±10.2 vs. 24.9±5.6 µg/ml; before vs. after treatment). These changes were accompanied by improved insulin sensitivity and reductions in visceral fat area. The latter was found to be highly correlated with the decline of serum RBP4 levels (r=0.471, p=0.027).
Conclusions Serum RBP4 level is positively associated with visceral adiposity in both men and women. Our data suggest that RBP4 may contribute to the development of insulin resistance along with other adipokines.
This article has been cited by other articles:
![]() |
T. M. Barber, M. Hazell, C. Christodoulides, S. J. Golding, C. Alvey, K. Burling, A. Vidal-Puig, N. P. Groome, J. A. H. Wass, S. Franks, et al. Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2859 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Choi, Y. J. Lee, Y. J. Park, K. W. Kim, E. J. Lee, S. Lim, D. J. Park, S. E. Kim, K. S. Park, H. C. Jang, et al. Retinol Binding Protein-4 Elevation Is Associated with Serum Thyroid-Stimulating Hormone Level Independently of Obesity in Elderly Subjects with Normal Glucose Tolerance J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2313 - 2318. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reinehr, B. Stoffel-Wagner, and C. L. Roth Retinol-Binding Protein 4 and Its Relation to Insulin Resistance in Obese Children before and after Weight Loss J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2287 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. de Ferranti and D. Mozaffarian The Perfect Storm: Obesity, Adipocyte Dysfunction, and Metabolic Consequences Clin. Chem., June 1, 2008; 54(6): 945 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mody, T. E. Graham, Y. Tsuji, Q. Yang, and B. B. Kahn Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E785 - E793. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |